JSPR
Jasper Therapeutics, Inc.
+0.08 (+13.43%)0.66USD195K成交股數21.9M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | 51K | −109K | −70K |
| 營業成本 | 3.6M | 3.6M | 9.3M | 15.8M | 9.8M | – | 8.8M | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.1M | 5.8M | 14.4M | 21.2M | 16.2M | 19.8M | 14.5M | 11.3M | 10.3M | 14.8M | 13.3M | 9.8M |
| 銷售管理費用 | 4.1M | 5.1M | 4.8M | 5.9M | 5.6M | 5.5M | 5.4M | 4.7M | 4.8M | 4.5M | 4.5M | 4.1M |
| 營業利益 | −9.2M-58% | −11.0M-57% | −19.2M-4% | −27.1M+69% | −21.8M+45% | −25.3M+31% | −19.9M+12% | −16.0M+15% | −15.1M | −19.4M | −17.8M | −13.9M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | -37,964.7% | 16,355.0% | 19,924.3% |
| 稅後淨利 | −2.8M-87% | −1.2M-95% | −18.7M+1% | −26.7M+83% | −21.2M+55% | −24.4M+39% | −18.6M+16% | −14.6M+2% | −13.7M | −17.5M | −16.1M | −14.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | -34,400.0% | 14,752.3% | 20,371.4% |
| 稀釋 EPS | -0.10-93% | -0.04-98% | -1.13-9% | -1.74+79% | -1.41+37% | -1.65+3% | -1.24-16% | -0.97-40% | -1.03 | -1.60 | -1.47 | -1.62 |
| 稀釋股數 | 28.7M | 28.7M | 16.6M | 15.3M | 15.0M | 14.6M | 15.0M | 15.0M | 13.3M | 11.0M | 10.9M | 8.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.3M | 14.1M | 50.9M | 39.5M | 48.8M | 71.6M | 92.5M | 107M | 118M | 104M | 116M | 129M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.8M | 21.2M | 57.5M | 46.5M | 57.6M | 79.9M | 99.4M | 114M | 126M | 110M | 124M | 139M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 10.4M | 17.8M | 45.9M | 23.0M | 15.4M | 18.2M | 15.7M | 13.6M | 12.7M | 16.3M | 14.0M | 13.6M |
| 股東權益 | 1.4M | 3.4M | 11.6M | 23.5M | 42.2M | 61.7M | 83.7M | 100M | 113M | 94.1M | 110M | 125M |
| 負債比 | 88.0% | 84.0% | 79.9% | 49.4% | 26.7% | 22.8% | 15.8% | 12.0% | 10.1% | 14.7% | 11.2% | 9.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −14.5M | – | – | −22.8M+45% | – | – | – | −15.7M | – | – | −10.3M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 21K | – | – | 279K | 285K | 500K | 300K | 288K | 300K | 300K | 274K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −75.80 | –% | -3.95 | – |
| FY2024 | – | – | −71.3M | –% | -4.89 | – |
| FY2023 | −246K | +113.9% | −64.5M | 26,219.5% | -6.18 | – |
| FY2022 | −115K | +43.8% | −37.7M | 32,769.6% | -10.33 | – |
| FY2021 | −80K | -27.9% | −30.6M | 38,296.3% | -2.69 | – |
| FY2020 | −111K | – | −31.7M | 28,530.6% | -5.17 | – |